Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease

MLA

Gabriela Perdomo Coral, et al. “Fibromax and Inflamatory Markers Cannot Replace Liver Biopsy in the Evaluation of Non-Alcoholic Fatty Liver Disease.” Minerva Gastroenterology, July 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....761c0956973334e1701b686b9928d9d8&authtype=sso&custid=ns315887.

APA

Gabriela Perdomo Coral, Gabriela Z. Port, Alessandra Peres, Caroline Buss, Fernanda Branco, Leonardo L Lardi, Gilson Pires Dorneles, Cristiane Valle Tovo, Sabrina Alves Fernandes, Angelo Alves de Mattos, Carolina Garcia Soares Leães, & Rodrigo Mayer Lul. (2020). Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease. Minerva Gastroenterology.

Chicago

Gabriela Perdomo Coral, Gabriela Z. Port, Alessandra Peres, Caroline Buss, Fernanda Branco, Leonardo L Lardi, Gilson Pires Dorneles, et al. 2020. “Fibromax and Inflamatory Markers Cannot Replace Liver Biopsy in the Evaluation of Non-Alcoholic Fatty Liver Disease.” Minerva Gastroenterology, July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....761c0956973334e1701b686b9928d9d8&authtype=sso&custid=ns315887.